Blinatumomab followed by POMP maintenance shows effectiveness for newly diagnosed patients
Novel three-drug regimen used to manage life-threatening developments
Dr. Mikkael Sekeres in his latest New York Times column
Mutational pattern in MDS is not random, study finds
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A Cleveland Clinic oncologist’s book reflects on patients’ and physicians’ shared journeys
Lower toxicity than conventional chemo
Groundbreaking study paves way for targeted therapy
Study shows risk of overtreating patients
Phase 3 results reported in NEJM
Gene mutations discovered in some patients may lead to malignancy
Advertisement
Advertisement